Exact Mass: 365.1474448
Exact Mass Matches: 365.1474448
Found 118 metabolites which its exact mass value is equals to given mass value 365.1474448
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ondansetron hydrochloride
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D003879 - Dermatologic Agents > D000982 - Antipruritics D002491 - Central Nervous System Agents
Propericiazine
C21H23N3OS (365.15617480000003)
Propericiazine is a phenothiazine of the piperidine group. It has been shown to reduce pathologic arousal and affective tension in some psychotic patients, while the symptoms of abnormal mental integration are relatively unaffected. It is a sedative phenothiazine with weak antipsychotic properties. It also has adrenolytic, anticholinergic, metabolic and endocrine effects and an action on the extrapyramidal system. It is used as an adjunctive medication in some psychotic patients, for the control of residual prevailing hostility, impulsiveness and aggressiveness. Pericyazine, like other phenothiazines, is presumed to act principally in the subcortical areas, by producing what has been described as a central adrenergic blockade. N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Pericyazine (Propericiazine) is a first-generation antipsychotic agent that is used as an adjunct to the short-term management of severe anxiety states and psychosis[1]. Pericyazine is a selective D2-dopamine receptor antagonist[2][3]. Pericyazine has adrenolytic, anticholinergic, and extrapyramidal effects[4].
Ampicilloyl
C17H23N3O4S (365.14091980000006)
Riddelliine N-oxide
cucoline
C19H24ClNO4 (365.13937740000006)
Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2].
cucoline
C19H23NO4.HCl (365.13937740000006)
Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2]. Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2].
Erucifoline N-oxide
A pyrrolizine alkaloid that is erucifoline in which the tertiary amino function has been oxidised to the corresponding N-oxide. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2256
9-Hydroxy-5,8,9-trimethyl-2,7,11-trioxa-16-azatetracyclo[11.5.1.04,8.016,19]nonadec-13-ene-3,6,10-trione
(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-omega-(methylsulfanyl)octan-1-imine
Periciazine
C21H23N3OS (365.15617480000003)
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Pericyazine (Propericiazine) is a first-generation antipsychotic agent that is used as an adjunct to the short-term management of severe anxiety states and psychosis[1]. Pericyazine is a selective D2-dopamine receptor antagonist[2][3]. Pericyazine has adrenolytic, anticholinergic, and extrapyramidal effects[4].
6-([1,4]BIPIPERIDINYL-1-SULFONYL)-BENZOTRIAZOL-1-OL
C16H23N5O3S (365.15215280000007)
N-[2-Hydroxy-2-(4-methoxyphenyl)ethyl]-2-(2-chloro-3,4-dimethoxyphenyl)ethylamine
C19H24ClNO4 (365.13937740000006)
2-Propanol, 1-((6-methoxy-9H-pyrido(3,4-b)indol-4-yl)oxy)-3-((1-methyl ethyl)amino)-, hydrochloride
1H-Indole,1-methyl-3-[5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazol-2-yl]-(9CI)
C20H19N3O4 (365.13754940000007)
Urea, N-cyclopropyl-N-[(1,2-dihydro-6-methyl-2-oxo-3-quinolinyl)methyl]-N-(2-fluorophenyl)- (9CI)
2-(5-Norborene-2,3-dicarboximido)-1,1,3,3-tetramethyluronium tetrafluoroborate
C14H20BF4N3O3 (365.15337680000005)
(S,E)-1-phenyl-N-(4-(trifluoromethyl)benzylidene)-2-(trimethylsilyloxy)ethanamine
1-butyl-2,3,3-trimethylbenzo[e]indol-3-ium,perchlorate
C19H24ClNO4 (365.13937740000006)
1-(1-ANTHRACENYLMETHYL)-4-(3-METHOXYPHENYL)-1H-[1,2,3]TRIAZOLE
C24H19N3O (365.15280440000004)
[10-[(4-phenyltriazol-1-yl)methyl]anthracen-9-yl]methanol
C24H19N3O (365.15280440000004)
4-[(3-Methyl-1-benzothiophen-2-yl)methyl]-N-(3-pyridinyl)-1-piper idinecarboxamide
C21H23N3OS (365.15617480000003)
5-tritylpyridine-2-carboxylic acid
C25H19NO2 (365.14157140000003)
4-[(3-Ethynylphenyl)amino]-6,7-bis(2-hydroxyethoxy)quinazoline
C20H19N3O4 (365.13754940000007)
Riddelliine N-oxide
A pyrrolizine alkaloid that is 13,19-didehydrosenecionane bearing two additional hydroxy substituents at positions 12 and 18, two additional oxo groups at positions 11 and 16 and an N-oxido substituent.
2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine
C19H19N5O3 (365.14878239999996)
5-Chloro-1H-indole-2-carboxylic acid{[cyclopentyl-(2-hydroxy-ethyl)-carbamoyl]-methyl}-amide
3-({[(3s)-3,4-Dihydroxybutyl]oxy}amino)-1h,2h-2,3-Biindol-2-One
C20H19N3O4 (365.13754940000007)
(2z,3e)-2,3-Biindole-2,3(1h,1h)-Dione 3-{o-[(3r)-3,4-Dihydroxybutyl]oxime}
C20H19N3O4 (365.13754940000007)
2-[[(2R)-2-amino-3-[(E)-N-hydroxy-C-(7-methylsulfanylheptyl)carbonimidoyl]sulfanylpropanoyl]amino]acetic acid
2-[1-[(2-Amino-2-phenylacetyl)amino]-2-oxopropyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
C17H23N3O4S (365.14091980000006)
(4E)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-14-oxido-2,9-dioxa-14-azoniatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione
N-[(E)-(3,4-dimethoxyphenyl)methylideneamino]-2-quinolin-8-yloxyacetamide
C20H19N3O4 (365.13754940000007)
4-(4-Ethoxycarbonylanilino)-2-quinazolinecarboxylic acid ethyl ester
C20H19N3O4 (365.13754940000007)
2-[(1-Methyl-3-indolyl)thio]-1-(4-phenyl-1-piperazinyl)ethanone
C21H23N3OS (365.15617480000003)
N-(4-acetamidophenyl)-4-(1,3-dioxo-2-isoindolyl)butanamide
C20H19N3O4 (365.13754940000007)
5-(4-fluorophenyl)-N-[2-(1-piperidinyl)phenyl]-4-oxazolecarboxamide
1-[1-[(4-Fluorophenyl)methyl]-5-methyl-2-oxo-3-pyridinyl]-3-(phenylmethyl)urea
[[4-(Dimethylamino)phenyl]-(2-methylpropoxy)phosphoryl]-(2-fluorophenyl)methanol
C19H25FNO3P (365.15560020000004)
jacozine N-oxide
A pyrrolizine alkaloid that is jacozine in which the tertiary amino function has been oxidised to the corresponding N-oxide.
(2R,3R,4R)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2R,3S,4S)-1-(5-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]azetidine-2-carbonitrile
C21H23N3OS (365.15617480000003)
(2R,3R,4S)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2S,3R,4S)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2R,3S,4R)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2S,3R,4R)-1-(5-ethyl-1,3-thiazol-2-yl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]azetidine-2-carbonitrile
C21H23N3OS (365.15617480000003)
(2S,3S,4S)-3-[4-(1-cyclopentenyl)phenyl]-1-(4-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2R,3S,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2S,3S,4R)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2S,3S,4S)-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-3-[4-(3-methylbut-1-ynyl)phenyl]-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2R,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-(4-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
(2R,3R,4R)-3-[4-(1-cyclopentenyl)phenyl]-1-(5-ethyl-2-thiazolyl)-4-(hydroxymethyl)-2-azetidinecarbonitrile
C21H23N3OS (365.15617480000003)
[(1S)-7-methoxy-2-methyl-1-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C17H23N3O4S (365.14091980000006)
Ethyl 2-methyl-4,5-dioxo-1-phenyl-3-phenyldiazenylpyrrolidine-2-carboxylate
C20H19N3O4 (365.13754940000007)
(5R,7S,9Z,12R,15R,18R)-9-ethylidene-7-(hydroxymethyl)-5-methyl-15-oxido-3,6,11-trioxa-15-azoniatetracyclo[10.5.1.05,7.015,18]octadec-1(17)-ene-4,10-dione
9-hydroxy-5,8,9-trimethyl-2,7,11-trioxa-16-azatetracyclo[11.5.1.0⁴,⁸.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
5-benzyl-7,10-dihydroxy-2-oxa-3,6,17-triazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-6,11,13,15-tetraen-4-one
C20H19N3O4 (365.13754940000007)
methyl 5-{3-hydroxy-9-oxo-1h,2h-pyrrolo[2,1-b]quinazolin-3-yl}-2-(methylamino)benzoate
C20H19N3O4 (365.13754940000007)
4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
C20H19N3O4 (365.13754940000007)
(4r,7r)-4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
C20H19N3O4 (365.13754940000007)
(1r,4z,7s,17r)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-14-ium-14-olate
(5r,7s,9z,12r,18r)-9-ethylidene-7-(hydroxymethyl)-5-methyl-4,10-dioxo-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-en-15-ium-15-olate
(1r,20r)-4-hydroxy-5,10-dimethyl-2,6,9,12-tetraoxa-17-azapentacyclo[12.5.1.1⁴,⁸.0⁸,¹⁰.0¹⁷,²⁰]henicos-14-ene-3,11-dione
(1'r,3s,6's,7'r,17'r)-7'-hydroxy-3,7'-dimethyldispiro[oxirane-2,4'-[2,9]dioxa-[14]azatricyclo[9.5.1.0¹⁴,¹⁷]heptadecane-6',2''-oxiran]-11'-ene-3',8'-dione
(3s,6s)-3-[(2ar)-2ah,3h-[1,2]dioxeto[3,4-b]indol-7b-ylmethyl]-6-benzyl-3,6-dihydropyrazine-2,5-diol
C20H19N3O4 (365.13754940000007)
(1r,5s,8s,10s)-5-benzyl-7,10-dihydroxy-2-oxa-3,6,17-triazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-6,11,13,15-tetraen-4-one
C20H19N3O4 (365.13754940000007)
1-benzyl-3,10-dihydroxy-1-methoxy-4-methyl-4h-pyrazino[2,1-b]quinazolin-6-one
C20H19N3O4 (365.13754940000007)
(1r,4r,5r,8s,9s,19r)-9-hydroxy-5,8,9-trimethyl-2,7,11-trioxa-16-azatetracyclo[11.5.1.0⁴,⁸.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
(1s,20s)-4-hydroxy-5,10-dimethyl-2,6,9,12-tetraoxa-17-azapentacyclo[12.5.1.1⁴,⁸.0⁸,¹⁰.0¹⁷,²⁰]henicos-14-ene-3,11-dione
4,5-bis(2h-1,3-benzodioxol-5-ylmethyl)-1-methyl-3h-imidazol-2-imine
C20H19N3O4 (365.13754940000007)
(4s,7r)-4-benzyl-6-hydroxy-4-methoxy-7-methyl-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
C20H19N3O4 (365.13754940000007)
(1s,4r)-1-benzyl-3,10-dihydroxy-1-methoxy-4-methyl-4h-pyrazino[2,1-b]quinazolin-6-one
C20H19N3O4 (365.13754940000007)